ROCTAVIAN Trademark

Trademark Overview

On Thursday, April 9, 2020, a trademark application was filed for ROCTAVIAN with the United States Patent and Trademark Office. The USPTO has given the ROCTAVIAN trademark a serial number of 88866355. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 6, 2024. This trademark is owned by Biomarin Pharmaceutical Inc.. The ROCTAVIAN trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for treating genetic diseases and disorders
roctavian

General Information

Serial Number88866355
Word MarkROCTAVIAN
Filing DateThursday, April 9, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 2, 2021

Trademark Statements

Description of MarkThe mark consists of the word "ROCTAVIAN" in stylized, red font located to the right of the depiction of a stylized representation of a tilted double helix that has a gradation in coloring from blue to purple.
Goods and Servicespharmaceutical preparations for treating genetic diseases and disorders
Indication of Colors claimedThe color(s) blue, purple and red is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, April 18, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiomarin Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameBiomarin Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events

Event DateEvent Description
Monday, April 13, 2020NEW APPLICATION ENTERED
Saturday, April 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 21, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, June 15, 2020ASSIGNED TO EXAMINER
Thursday, June 18, 2020NON-FINAL ACTION WRITTEN
Thursday, June 18, 2020NON-FINAL ACTION E-MAILED
Thursday, June 18, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 4, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 4, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 30, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 30, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 9, 2021SOU TEAS EXTENSION RECEIVED
Thursday, September 9, 2021SOU EXTENSION 1 FILED
Thursday, September 9, 2021SOU EXTENSION 1 GRANTED
Saturday, September 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 24, 2022SOU TEAS EXTENSION RECEIVED
Thursday, March 24, 2022SOU EXTENSION 2 FILED
Thursday, March 24, 2022SOU EXTENSION 2 GRANTED
Saturday, March 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 30, 2022SOU TEAS EXTENSION RECEIVED
Friday, September 30, 2022SOU EXTENSION 3 FILED
Friday, September 30, 2022SOU EXTENSION 3 GRANTED
Tuesday, October 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 24, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 24, 2023SOU EXTENSION 4 FILED
Friday, March 24, 2023SOU EXTENSION 4 GRANTED
Tuesday, March 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 25, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 25, 2023SOU EXTENSION 5 FILED
Tuesday, October 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 3, 2023SOU EXTENSION 5 GRANTED
Wednesday, October 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 6, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, May 6, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

roctavian diseases disorders genetic treating preparations pharmaceutical